OTO-313

· Otonomy, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OTO-313, covering 2022-12-23 to 2023-01-06. Get the full timeline:

Most recent: Clinical Trial Update: OTO-313 in Subjects With Unilateral Subjective Tinnitus [Phase 2]